PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

MLA

Fortunato Ciardiello, et al. “PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?” Frontiers in Oncology, vol. 10, June 2020. EBSCOhost, https://doi.org/10.3389/fonc.2020.00782.

APA

Fortunato Ciardiello, Sara Centonze, A. Diana, Elisena Franzese, Ferdinando De Vita, Michele Orditura, & Sandro Pignata. (2020). PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts? Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.00782

Chicago

Fortunato Ciardiello, Sara Centonze, A. Diana, Elisena Franzese, Ferdinando De Vita, Michele Orditura, and Sandro Pignata. 2020. “PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?” Frontiers in Oncology 10 (June). doi:10.3389/fonc.2020.00782.